Krystal Biotech Inc

NASDAQ:KRYS   12:46:31 PM EDT
71.35
+2.20 (+3.18%)
Products

FDA Accepts Krystal Biotech's BLA For Dystrophic Epidermolysis Bullosa

Published: 08/18/2022 21:29 GMT
Krystal Biotech Inc (KRYS) - FDA Accepts Krystal Biotech’s Biologics License Application for Dystrophic Epidermolysis Bullosa.
Krystal Biotech Inc - PDUFA Target Action Date is February 17, 2023.
Krystal Biotech Inc - FDA Stated That It is Not Currently Planning to Hold an Advisory Committee Meeting.